Standard BioTools Inc.
LAB
$1.07
-$0.045-4.04%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -44.18% | 154.91% | 184.31% | 177.37% | 199.14% |
| Total Receivables | -1.48% | 70.95% | 113.27% | 114.57% | 148.29% |
| Inventory | 4.38% | 98.40% | 94.48% | 93.02% | 79.27% |
| Prepaid Expenses | -6.28% | 176.97% | 173.68% | 187.55% | 164.14% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -37.17% | 137.58% | 165.67% | 162.21% | 180.91% |
|
|
|||||
| Total Current Assets | -37.17% | 137.58% | 165.67% | 162.21% | 180.91% |
| Net Property, Plant & Equipment | 14.08% | 30.14% | 29.64% | 30.65% | 7.38% |
| Long-term Investments | 5.13% | 4.68% | 0.11% | -0.03% | -0.02% |
| Goodwill | 5.13% | 4.68% | 0.11% | -0.03% | -0.02% |
| Total Other Intangibles | -30.37% | 1,968.14% | 446.72% | 232.48% | 294.65% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 16.44% | 986.61% | 1,021.63% | 866.24% | 843.99% |
| Total Assets | -25.47% | 89.54% | 100.88% | 99.18% | 109.24% |
|
|
|||||
| Total Accounts Payable | -10.37% | 32.98% | 49.12% | 106.44% | 115.11% |
| Total Accrued Expenses | -20.25% | 34.34% | 35.97% | 23.82% | 14.87% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -89.53% | -90.25% | 579.68% | 613.76% | 752.33% |
| Total Finance Division Other Current Liabilities | -20.56% | 27.90% | 37.98% | 93.46% | 98.44% |
| Total Other Current Liabilities | -20.56% | 27.90% | 37.98% | 93.46% | 98.44% |
| Total Current Liabilities | -53.74% | -39.73% | 132.85% | 164.32% | 177.60% |
|
|
|||||
| Total Current Liabilities | -53.74% | -39.73% | 132.85% | 164.32% | 177.60% |
| Long-Term Debt | 0.00% | -92.49% | -99.50% | -99.51% | -99.52% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -19.97% | -12.86% | -9.66% | -8.11% | -6.16% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.06% | 196.40% | 150.71% | 145.48% | 150.98% |
| Total Liabilities | -37.61% | -12.04% | 20.32% | 25.65% | 27.16% |
|
|
|||||
| Common Stock & APIC | 2.18% | 97.77% | 97.06% | 97.16% | 97.03% |
| Retained Earnings | -12.30% | -18.48% | -17.39% | -17.15% | -14.42% |
| Treasury Stock & Other | -140.69% | -451.87% | -517.60% | -589.68% | -331.95% |
| Total Common Equity | -21.26% | 418.62% | 471.49% | 550.02% | 694.23% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -21.26% | 418.62% | 471.49% | 550.02% | 694.23% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -21.26% | 189.04% | 172.56% | 157.88% | 169.65% |
|
|
|||||